The Trump administration’s abrupt freeze on federal science communication and grant processes threw researchers into chaos, delaying critical projects and threatening the future of public health research.
In short:
- The administration halted communications at the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and other agencies, stalling grant reviews and disrupting scientific meetings.
- Clinical trials, including experimental cancer treatments, face uncertainty, while labs struggle to buy supplies or repair essential equipment.
- Scientists fear this signals a broader attack on government-funded research, with long-term consequences for disease treatment and public health innovation.
Key quote:
“The NIH freak-out may have less to do with the present disruption (however long it lasts) than with what it signifies.”
— Ian Bogost, professor at Washington University in St. Louis
Why this matters:
This kind of disruption can ripple through entire fields, delaying the rollout of critical treatments and leaving patients hanging. With Trump allies pushing to gut federal science, researchers warn that the damage could outlast the administration, making the U.S. a less reliable leader in global health and innovation.
Read more:
Want to keep toxic chemicals out of the environment? Start with campaign finance reform.
